Move your customers from retail Cannabidiol to prescription cannabidiol. We provide licensed clinicians, LegitScript Certified pharmacies, and prescription-strength dosing. You keep your brand and your customer list.
A licensed clinician decides every prescription · Live within weeks: clinicians and pharmacies already credentialed · Eligibility confirmed by shipping state at intake
total THC allowed per container after December 11; one dropper of a typical full-spectrum Cannabidiol oil already exceeds it.¹
THC was not detected by an independent third-party laboratory in the sample batch tested.⁴
of hemp-derived cannabinoid products sold today fall outside the new definition (industry estimate).²
LegitScript certifications available to ingestible retail Cannabidiol.³
Sources: 1. Federal hemp definition (CRS); Johnson et al., Drug & Alcohol Dependence, 2022 (median 0.64 mg THC/mL in THC-positive Cannabidiol oils) · 2. Wilson Elser, “The Great Hemp Reset,” 2026 · 3. LegitScript Cannabidiol Certification eligibility · 4. Certificate of Analysis, Triverity Laboratories (ISO/IEC 17025 accredited), batch 2298453, Sep 2026, available on request; Johnson et al. 2022

On December 11, a new federal rule caps hemp products at 0.4 mg of total THC per container. One dropper of a typical full-spectrum Cannabidiol oil already goes over. Industry estimates put roughly 95% of hemp-derived cannabinoid products sold today outside the new definition.
The damage starts before the deadline. Payment processors and ad platforms are already pulling accounts. Legal counsel is flagging product-liability policies written for a product that’s about to be reclassified, shipments caught mid-transit, e-commerce delistings, and lenders asking about inventory (Wilson Elser, 2026).
You introduce the program through your existing storefront and customer list, with marketing assets supplied by Kazmira.
A clinician reviews the patient's intake and medications, asynchronously or by a live visit where state rules require one, and decides whether prescription cannabidiol is appropriate.
A LegitScript Certified pharmacy compounds the prescribed dose with Kazmira's THC-free cannabidiol and ships it under your brand.
Pharmacist check-ins, monthly refills, and dose adjustments when appropriate, all running through your storefront. Same customer relationship, a different level of care.
“The calls have already started. Operators who built real brands and real customer lists in the hemp space are being told by their payment processors that they have weeks, not years,”

Beyond processing, legal counsel is flagging product-liability policies written for a product that's about to be reclassified, shipments caught mid-transit, e-commerce delistings, and lenders asking about inventory.
Source: Wilson Elser, “The Great Hemp Reset: How the Federal Ban on Intoxicating Hemp Products Will Reshape Risk and Coverage”
The demand your customers built isn’t going anywhere; it can no longer be served over the counter. The prescription pathway is regulated under pharmacy law rather than the hemp definition, so neither the November 12 nor the December 11 deadline touches it.
Beyond December 11, a better reason for customers to choose you: most retail Cannabidiol leaves the customer to figure out the product, the dose and the results on their own.
A typical serving holds 5 to 20 mg. Most positive clinical trials used more than 300 mg a day (Chesney et al., 2020), and about 7 in 10 Cannabidiol products sold online are mislabeled (Bonn-Miller et al., JAMA, 2017).
* Certificate of Analysis, Triverity Laboratories (ISO/IEC 17025 accredited), batch 2298453, Sep 2026, available on request.
† Refining crude oil means separating thousands of similar molecules into pure fractions. Kazmira’s founders learned that work as chemical engineers in oil and gas, then spent more than a decade applying it to the 100+ compounds in cannabis.
Keep your customers. Your existing customers are the first people you invite. Start before December 11.
Keep your brand. Patients order on your storefront, get support in your name, and receive their prescription under your brand. API-first, so it runs alongside the systems you already have.
Revenue that renews every month. Approved patients refill monthly, as prescribed, through your storefront.
Your patients stay yours. The customer relationship belongs to your storefront. Kazmira fills the prescriptions and doesn’t market to your patients.
Clinicians who know cannabidiol. Training in Kazmira’s clinical protocols (dosing, titration and drug-interaction screening) is available to every prescriber in your network.
A storefront that stands apart. Retail competitors sell another bottle. You offer a prescription program with a clinician and a pharmacist behind it.
API manufacturing, a licensed 503A compounding pharmacy, and a clinician-led telehealth platform, under one roof.
Kazmira, founded in 2016, now runs the nation's first 503A compounding pharmacy dedicated to prescription-only, THC-free Cannabidiol, launched January 2026.
Kazmira developed the method to remove every detectable trace of THC from cannabidiol at scale: 29 steps of proprietary purification under cGMP, ICH Q7 and ISO 9001 standards.
THC was not detected by an independent third-party laboratory in the sample batch tested, and potency within 3% of label claim (Certificate of Analysis, Triverity Laboratories, ISO/IEC 17025, available on request). Three strengths: 6,000, 9,000 and 12,000 mg bottles, one for each prescribed daily dose.
Verifiable at legitscript.com. Ingestible retail Cannabidiol is not eligible for this certification.
Pharmaceutical-grade API manufactured and third-party tested domestically.
Quoted in Forbes Health and Denver7; covered by MediaPost, FOX31, the Denver Gazette, Cannabis Business Times and MDLinx; featured in MedCity News.
1Cannabis™, Kazmira’s education platform for clinicians and patients, launched in April 2026 with dosing and drug-interaction protocols built over 18 months.
LegitScript Certified pharmacy fulfillment. Kazmira Pharmacy and its licensed partner hold the state licenses and fill every order, with eligibility confirmed by shipping state at intake.
Licensed clinician network. Credentialed clinicians review each patient and decide whether to prescribe.
Pharmaceutical-grade, THC-free cannabidiol API. Purified by Kazmira in Watkins, Colorado, and third-party tested.
Compounding and shipping. The pharmacy compounds each patient's dose and ships it to their door.
Marketing assets supplied by Kazmira. Ads, images and claim language, cleared by Kazmira before they reach you. We recommend that each storefront obtain its own legal review of marketing materials before use.
White-label patient support. Patient questions answered under your brand's name.
Analytics and performance monitoring. Ongoing monitoring and reporting on your program's performance.
API-first integration. Connects to the storefront, EHR and fulfillment stack you already run.
Kazmira's pharmaceutical-grade, THC-free cannabidiol, offered through CareValidate as a turnkey prescription program: licensed clinicians, THC-free cannabidiol compounded by LegitScript Certified pharmacies, and white-label fulfillment, launched under your own brand.
Yes. Every prescription is THC-free, under the new 0.4 mg per-container limit, and dispensed by licensed pharmacies under state pharmacy law. Kazmira’s counsel has reviewed the program against both federal hemp deadlines, November 12 and December 11.
Eligibility is confirmed by shipping state at intake. The program is live in a growing list of states; we’ll walk through the current footprint on the demo.
Most programs go live within weeks. The clinician network and pharmacies are already credentialed.
No. A credentialed clinician network and Kazmira's LegitScript Certified pharmacy are included.
If your customers buy Cannabidiol for daily wellness, yes: bring your brand and your customer list into the prescription pathway before December 11. Every prescription is THC-free, so it won't replace products people buy for a THC effect.
You do. Patients come through your storefront and stay your customers. Kazmira fills the prescriptions and does not market to your patients.
Yes. Patients complete intake and clinician review online, and the pharmacy ships each prescription to their door. If you also run a physical store, you can point in-store customers to your online storefront.
It depends on your program and customer base. We walk through pricing on the demo.
The intake is online and the clinician review is asynchronous in most states. A pharmacist and clinician follow up with each patient afterward.
Often it comes down to dose and label accuracy (see the dose gap above). Here, a clinician sets the dose, adjusts it at follow-up, and the pharmacy fills it with lab-verified cannabidiol.
Cannabidiol is taken daily as prescribed. A pharmacist checks in around week two, and a clinician follows up to adjust the dose if needed.
No. A licensed clinician decides whether cannabidiol is appropriate for each patient.
Kazmira supplies pre-approved assets and claim language and reviews anything that names the medication or makes a clinical claim, per your Brand Schedule. CareValidate manages platform compliance. Comparisons to FDA-approved drugs aren't permitted.
Yes. The pharmacy behind the program is LegitScript Certified, the same independent standard the card networks and Google use to verify online pharmacies.
No. The integration is API-first and connects to your current storefront, EHR and fulfillment stack.
Book a demo and we’ll plan your launch before the deadline, whether you’re moving an existing hemp/Cannabidiol brand or launching fresh.

Not all patients are eligible. No guarantee of prescription or outcome. Compounded medications are not FDA-approved. Educational information only; not medical advice.